Background: For many malarious regions outside of Africa, development of effective transmission-blocking vaccines will require coverage against both Plasmodium falciparum and P. vivax. Work on P. vivax transmissionblocking vaccines has been hampered by the inability to clone the vaccine candidate genes from this parasite. Materials and Methods: To search for genes encoding the ookinete surface proteins from P. vivax, the DNA sequences of the eight known proteins in the P25 subfamily (Pfs25, Pgs25, Pys25, Pbs25) and in the P21/28 subfamily (Pfs28, Pgs28, Pys21, Pbs21) of zygote/ookinete surface proteins were aligned. Regions of highest identity were used to design degenerate PCR oligonucleotides. Genomic DNA from the Sal I strain of P. vivax and genomic and splinkerette DNA libraries were used as PCR templates. To characterize the polymorphisms of Pvs25 and Pvs28, these two genes were PCR amplified and the DNA sequences were determined from genomic DNA extracted from patients infected with P. vivax.
laria occur mainly in subSaharan African children under 5 years old who are infected with Plasmodium falciparum (1) . As drug-resistant parasite strains render chemoprophylaxis increasingly ineffective, a greater need exists for new control strategies, such as malaria transmissionblocking vaccines. The primary function of transmission-blocking vaccines is to prevent the spread of malaria parasites between humans by blocking mosquito transmission. Transmissionblocking vaccines would be useful as a public health measure to either control or prevent the re-introduction of malaria in geographically isolated areas, and would also be useful in a multicomponent malaria vaccine to prevent the spread of vaccine escape mutants resistant to the protective components of such a vaccine or in combination with chemotherapeutic agents to prevent the spread of drug-resistant parasites (2) .
The targets of transmission-blocking immunity are proteins expressed by the sexual/sporogonic stages (gametocytes, gametes, zygotes, ookinetes, and oocysts) of Plasmodium ssp. and by the mosquito midgut (3) . In the postfertilization (zygote and ookinete) stages of P. falciparum, prime vaccine candidates include Pfs25 and Pfs28, predominant surface antigens of 25 and 28 kDa, respectively (4, 5) . The analogous proteins, Pgs25 and Pgs28, from the evolutionarily related avian malaria parasite, P. gallinaceum, have been previously described (6, 7) . These proteins have four epidermal growth factor (EGF)-like, cysteine-rich domains that are thought to be anchored to the surface of the parasite by glycosyl phosphatidylinositol (GPI) moieties. Unlike Pfs25 and Pgs25, Pfs28 and Pgs28 have four rather than the usual six cysteines in the fourth EGF-like domain. Recently, the analogous proteins, Pys25 and Pys21 (8, 9) , from the rodent malaria parasite, P. yoelii, and Pbs25 (10) and Pbs21 (1 1), from another rodent malaria parasite, P. berghei, have been described. Although P. vivax is an important human pathogen responsible for much of the morbidity resulting from malaria and in which drug resistance has recently been described (12) , comprehensive immunologic and biochemical studies on this parasite have been limited. This is mainly because continuous in vitro culture of P. vivax has not been routinely established (13) ; consequently, access to sufficient quantities of P. vivax has limited the progress of basic research, including the strategy of protein purification and microsequencing as the basis for cloning relevant genes. There are only a few reports that describe the P. vivax target antigens of transmission-blocking immunity. Premawansa et al. (14) raised several transmissionblocking monoclonal antibodies (MAbs) against P. vivax female gametes that recognized 20 to 200 kDa determinants. Unlike the target antigens described for P. falciparum, the majority of target antigens from P. vivax were found to be polymorphic. Snewin et al. (15) cloned a gene from a A-gtl 1 P. vivax genomic expression library by using one of these anti-gamete MAbs that recognizes a linear epitope; however, no significant homology was found to sequences of known zygote/ookinete surface protein genes in the GenBank. Because of the lack of significant cross-reactive immunity and the lack of DNA cross-hybridization between P. falciparum and P. vivax, the characterization of speciesspecific molecules that are targets of transmissionblocking immunity is required for the development of an effective P. vivax transmission-blocking vaccine. Although two cysteine-rich ookinete surface proteins in the P. vivax-like monkey malaria parasite, P. knowlesi, were identified by MAbs several years ago (16), these MAbs have had limited utility in screening prokaryotic expression libraries of P. vivax target antigen genes because all of the MAbs recognized reduction-sensitive epitopes that are unlikely to be recreated in the reducing environment of E. coli. To date, many researchers have tried unsuccessfully to isolate the analogous genes from P. vivax ookinetes (3, 17) . Waters et al. (18) reported the phylogenetic tree for the genus Plasmodium based on a speciesspecific region of the asexually expressed SSU rRNA gene. P. vivax is situated between the rodent branch and avian branch, the latter of which includes P. falciparum. On the basis of these data, we hypothesized that the P. vivax homologues of the ookinete surface protein genes would be situated between rodent and avian homologues. Here [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] and finally 6 min (cycles [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] .
In the primary PCR reaction, 0.25 ,lI of ligation product was amplified in 25 ,ul. Secondary PCR was performed using 0.5 ,ul primary PCR product as a template in 25 ,lI. The PCR conditions were as follows: 94°C for 10 min, then 10 cycles of 940C for 30 sec, 550C for 15 sec, and 720C for 2 min; then 10 cycles of 940C for 30 sec, 550C for 15 sec, and 720C for 4 min; then 10 cycles of 940C for 30 sec, 550C for 15 sec, and 720C for 6 min; and finally 72°C for 4 min. The 5' end of Pvs28 was cloned using pairs of genespecific and splinkerette-specific primers (for the first PCR-splinkerette #1 primer: see above, and anti-sense strand gene-specific primer 5' -TGG TGC TGT TCA CAT TAG CG-3'; for nested PCRsplinkerette #2 internal primer: see above; and anti-sense strand gene-specific internal primer: 5'-TTT GCC AGA ACA AAC CCG TCG-3'). A pair of gene-specific PCR primers (sense: 5'-CTA CCA CAG CTT GCT GTT CC-3'; anti-sense: 5'-TGA CAT CAT GAA GAA GGC G-3') at each end of the gene sequence was used to amplify fulllength ORF of the Pvs28 gene from the P. vivax Sal I genomic library (as above) or genomic DNA obtained from field isolates using pfu DNA polymerase (Stratagene). After purification of the specific DNA fragment, we directly sequenced the DNA fragment using Pvs28-specific PCR primers (see above) as sequencing primers (ABI PRISM 310 Genetic Analyzer; PE Applied Biosystems) for the DNA fragment from Sal I, or sequenced the DNA fragment after cloning into the pCR-Script vector (Stratagene).
CLONING OF Pvs25. The gene sequences of the nine known proteins, Pfs25, Pgs25, Pys25, Pbs25, Pvs28, Pfs28, Pgs28, Pys2 1, and Pbs2 1, were aligned. To prevent amplification of the Pvs28 gene, a nucleotide sequence from a conserved region of the first EGF-like domain was chosen for synthesis of a degenerate PCR oligonucleotide primer (sense primer: 5'-GG(AT) 1TT (CT)T(AG) (AG)(CT)T CA(AG) ATG AGT-3') such that the primer would not be identical to the Pvs28 sequence. Using this primer in a PCR reaction (940C for 10 min, then 30 cycles of 94°C for 30 sec, 440C for 60 sec, and 720C for 2 min 30 sec, and finally 720C for 8 min) with a plasmid-specific M13 forward primer (5'-GTA AAA CGA CGG CCA GT-3'), two different-sized DNA fragments were amplified from the P. vivax pUC18 genomic library. The PCR products were again amplified using an internal degenerate primer (sense primer: 5'-TCA (AG)AT GAG T(AG)(AG) (CT)CA FTT (AGT)GA ATG-3') with a plasmidspecific M13 forward primer (see above) (94°C for 10 min, then 30 cycles of 940C for 30 sec, 44°C for 30 sec, and 720C for 1 min, and finally 720C for 10 min). After purification of the individual DNA fragments, each fragment was subcloned into pCR2.1 (Invitrogen) and, using plasmid-specific sequencing primers, eight individual recombinant plasmid clones were completely sequenced (ABI PRISM 310 Genetic Analyzer, PE Applied Biosystems). The complete sequence of the DNA for Pvs25 was determined from DNA amplified from the nested splinkerette PCR using pairs of gene-specific and splinkerette-specific primers (for the first PCR-splinkerette #1 primer: see above, and anti-sense strand Pvs25-specific primer: 5'-GGA CAA GCA GGA TGA TAA AG-3'; for nested PCR-splinkerette #2 internal primer: see above, and anti-sense strand Pvs25-specific internal primer: 5'-AGC ACA CAA GTG TCT TCC TTCC-3'). The template DNA for the PCR was a splinkerette genomic DNA library of P. vivax Sal I strain. Primary PCR combined Hot Start and Touchdown protocols; conditions were as follows: denaturation, 94°C for 10 min in the first cycle and 30 sec thereafter; annealing, 1 min at 60°C initially, decreasing by 2°C to 500C per cycle and 500C thereafter; extension, 720C for 2 min (cycles 1-10), then 4 min (cycles [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] , and finally 6 min (cycles [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] Analysis of the amino acid sequence of Pvs28 deduced from the 693 bp single ORF revealed a presumptive secretory signal sequence, four EGF-like domains, six copies of the tandemly repeated heptad (Gly-Ser-Gly-Gly-Gln/Asn), and-typical of GPI-anchored proteins of malaria parasites-a short hydrophobic region at the carboxy terminus. The deduced amino acid sequence had 20 cysteines arranged in a pattern characteristic of EGF-like domains. Analysis of the amino acid sequence deduced from the 657 bp ORF of Pvs25 revealed a presumptive secretory signal sequence, four EGF-like domains with a total of 22 cysteines, and a short hydrophobic region at the carboxyterminus (Fig. 1) .
In Table 1 , the overall sequence identities of Pvs25 and Pvs28 are compared with each other and with the other known family members. The sequence identities of Pvs25 are highest with Pfs25 (45%) and Pgs25 (45%). Substantial sequence similarities also exist between Pvs25 and the other proteins, but the similarities between Pvs25 and the P25 subfamily members were higher than those between Pvs2 5 and the P21/28 subfamily members. In contrast, the sequence identities of Pvs28 are highest with Pys2l (43%). The similarities between Pvs28 and the P21/28 subfamily members were higher than those between Pvs28 and the P25 subfamily members.
Analysis of the phylogenetic tree for the genus Plasmodium, based on the amino acid sequences of ookinete surface proteins, suggests that both Pvs25 and Pvs28 are situated between rodent and avian P25 and P21/28 homologues, respectively (Fig. 2) . These results are in agreement with those reported by Waters et al. (18) based on phylogenetic analysis of asexually expressed SSU rRNA genes.
The ookinete surface proteins of P. falciparum, Pfs25 and Pfs28, which are thought to be expressed predominantly while the parasite resides in the mosquito, are unusually highly conserved for malaria surface antigens. Only two conserved amino acid substitutions were found in Pfs25 and one conserved substitution in Pfs28 to date (22) (23) (24) . We examined the sequence diversity of the Pvs25 and Pvs28 genes from a laboratory strain (Sal I), an Indian isolate, and two isolates from Bangladesh (Table 2 ). In Pvs25, we found only three point mutations that would result in amino acid substitutions: two conservative amino acid substitutions (Glu-97 to Gln-97, Gln-131 to Lys-131) and a single nonconservative substitution (Ile-130 to Thr-130). In contrast, the Pvs28 gene, despite being expressed later in the mosquito stages (and thus less apt to have been under immune selection by the vertebrate host), had more point mutations, but all were conservative substitutions, e.g., Met-52 to Leu-52, Thr-65 to Lys-65, Leu-98 to Ile-98, to Val-116, Thr-140 to Ser-140, Lys-159 to Arg-159, and Ile-224 to Met-224. All the amino acid substitutions reported in this study appear to be dimorphic, similar to the dimorphic patterns previously described for the P. falciparum merozoite surface protein 1 (MSP1) (25) . The most striking variation we detected in Pvs28 was the four tandem repeats of Gly-Ser-Gly-Gly-Glu/Asp found only in the Indian isolate. All other isolates had six copies of Gly-Ser-Gly-Gly-Glu/Asp repetitive peptides.
When we compared the deduced amino acid sequences of Pvs25 and Pvs28 obtained from the field isolates with those from the Sal I strain plotted on the presumed structure of the EGFlike domain, we found that the amino acid substitutions are mainly within the EGF-like domains (i.e., map to regions II-VI and not the flanking sequences in regions I and VII); however, in comparison with formerly published point mutation sites of Pfs25 and Pfs28 (22) (23) (24) , the regions of amino acid substitutions in Pvs25 and Pvs28 map to different regions of the EGFlike domains (Fig. 3) . Between 
aPositions of amino acid substitution are indicated by using amino acid position numbers based on amino acid sequences from Pvs25 or Pvs28 from P. vivax Sal I strain. fourth EGF-like domain has four instead of six cysteines (3). A unique feature of the P21/28 homologues appears carboxy-terminal to the fourth EGF-like domain. We observed in Pvs28 multiple copies of a heptad repeat consisting of Gly-Ser-Gly-GlyGln/Asn (Fig. 4) . The P. yoelii P21/28 homologue, Pys2 1, contains five copies of a Gly-Thr-Gly-Ser/ Thr repeat (9) , while the avian homologue, Pgs28, contains a series of Gly, Ser, and Pro residues (7) in this same region. In contrast, the P. berghei P21/28 homologue Pbs21 has only one Gly-Thr-Gly-Ser peptide sequence at the same position (1 1), and the P. falciparum homologue Pfs28 has no repeat sequences (5) . This region of the P21/28 homologues was found to be most divergent among members of this subfamily. A computer-based motif analysis indicated that these repetitive amino acid sequences are predicted to be highly immunogenic (data not shown). It remains to be determined what importance these regions have in the function or structure of the P21/28 subfamily proteins.
The data summarized in Table 1 are consistent with the notion that these two subfamilies, P25 and P21/28, were present in the common ancestor of all Plasmodium spp., because in general, subfamily members from all species are more similar to one another than they are to members of the other subfamily (9) . The evolutionary mechanisms responsible for the global divergence of these zygote/ookinete surface antigens between species and the divergence between the P25 and P21/28 homologues within each species of Plasmodium are not yet known. The deoxyguanosine plus deoxycytidine (dG + dC) contents of genomic DNA of the avian malaria parasites P. falciparum and P. lophurae and of the rodent parasite P. berghei are lower than that of the simian malaria parasites P. vivax and P. knowlesi (26) . Analyses of the %GC contents of the ookinete surface protein genes reveal that the %GC contents of Pvs25 and Pvs28 are much higher than those from the other Plasmodium ssp. (Table 1 (27) . By site-directed mutagenesis studies of the human EGF, an arginine residue between the fifth and the sixth cysteine residues appears to be the most influential, in that it appears to be involved both in receptor binding and in the structural integrity of EGF (28) . Until the function of this family of sexualstage surface proteins is better defined, the immunologic and the functional importance of these three regions of point mutations in ookinete surface proteins Pfs25, Pfs28, Pvs25, and Pvs28 remain to be determined.
A prototype malaria transmission-blocking vaccine based on Pfs25 expressed as a secreted recombinant protein from yeast has elicited transmission-blocking antibodies in primates (29) and is in human clinical trials (30) . Pfs28 has also elicited transmission-blocking antibodies in mice (5) . With the isolation of the genes encoding Pvs25 and Pvs28 described here and the possibility of developing transmission-blocking vaccines of P. vivax as previously described (19, 31) , Pvs25 and Pvs28 should now be considered in the development of a multitarget/multispecies transmission-blocking vaccine to control and/or eradicate malaria from geographically isolated areas that have both P. falciparum and P. vivax malaria. Differences in the intensity of transmission and consequently of acquired immunity in different areas can lead to major dif-Y.C .
[G.G****************REPEATS**************]C.. .S..N.. Pfs28 (5), and Pgs28 (7) in the P21/28 subfamily. 28con represents the consensus amino acid sequence in the P21/28 subfamily members. Dots in the consensus amino acid sequences are residues nonidentical to the sequences in P21/28 subfamily members. ferences in the nature of the reservoir of infection (32) (33) (34) . Before applying the transmissionblocking vaccine to a P. vivax malaria-endemic region, such as Papua New Guinea or Sri Lanka, we need to evaluate the estimates of the human reservoir of infection for preventing the increase in gametocyte-positive infections (35) and the implications of pre-existing polymorphisms in Pvs25 and Pvs28.
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